Professor, Internal Medicine, Mayo Medical School
Gastroenterology
Dr. Patrick S. Kamath, MD
|
|
Give Review
Patrick Kamath is an expert in the field of Gastroenterology. He graduated from St. John's Medical College. Patrick Kamath has written publications. He has 99 publications published with PubMed. The lastest paper is: 'Readmission in Cirrhosis: a Growing Problem.' Patrick S. Kamath accepts all Medicare patients.
Publications
- Alcohol stimulates macrophage activation through caspase-dependent hepatocyte derived release of CD40L containing extracellular vesicles.
- Liver Disease in Patients After the Fontan Operation.
- Nonselective β-Blockers and Survival in Patients With Cirrhosis and Ascites: A Systematic Review and Meta-Analysis.
- Primary Biliary cirrhosis by another name is still PBC.
- Variations in albumin use in patients with Cirrhosis: An AASLD members survey.
- Lack of Health Insurance Limits the Benefits of Hepatitis C Virus Screening: Insights from the National Health and Nutrition Examination Hepatitis C Follow-Up Study.
- Epidemiology, Diagnosis and Early Patient Management of EsophagoGastric Hemorrhage.
- A cut-off serum creatinine value of 1.5mg/dl for AKI - To be or not to be.
- From vitamin k antagonists to liver international normalized ratio: a historical journey and critical perspective.
- Editorial: neutrophil dysfunction in patients with Cirrhosis.
- Editorial: sepsis in Cirrhosis - there may be trouble ahead; authors' reply.
- Efficacy of Endoscopic Ultrasound-guided Hemostatic Interventions for Resistant Non-variceal Bleeding.
- Identifying the presence of clinically significant hepatic involvement in hereditary haemorrhagic telangiectasia using a simple clinical scoring index.
- Toward an Improved Definition of Acute-on-Chronic Liver Failure.
- Prevalence and in-hospital mortality trends of infections among patients with Cirrhosis: a nationwide study of hospitalised patients in the United States.
- Current epidemiology of Hepatitis E virus infection in the United States: Low seroprevalence in the National Health and Nutrition Evaluation Survey.
- Alcoholic Hepatitis: current challenges and future directions.
- New anticoagulant and antiplatelet agents: a primer for the gastroenterologist.
- Survival in infection-related acute-on-chronic liver failure is defined by extra-hepatic organ failures.
- Prediction of Early Mortality After Variceal Bleeding: Score One More For MELD.
- Role of Magnetic Resonance Elastography in compensated and decompensated liver Disease.
- Liver Stiffness Is Associated With Risk of Decompensation, Liver Cancer, and Death in Patients With Chronic Liver Diseases: A Systematic Review and Meta-analysis.
- Nutritional status of patients with alcoholic Cirrhosis undergoing liver transplantation: time trends and impact on survival.
- Management of antithrombotic therapy in patients undergoing invasive procedures.
- Natural history of Cirrhosis.
- Second infections independently increase mortality in hospitalized patients with Cirrhosis: the North American consortium for the study of end-stage liver disease (NAC...
- Acute-on-Chronic Liver Failure: What are the Implications?
- Lack of significant liver enzyme elevation and Gallstones and/or sludge on ultrasound on day 1 of acute pancreatitis is associated with recurrence after cholecystectom...
- Intensive care of the patient with Cirrhosis.
- Prevalence of Spontaneous PortoSystemic Shunts in Patients with Portopulmonary Hypertension and Effect on Treatment.
- Publications in HEPATOLOGY: Is there a Pro-United states bias?
- Born to be wild or just confused? genetic predisposition to hepatic encephalopathy.
- Acute-on-chronic liver failure: concept, natural history, and prognosis.
- Influence of serum sodium on MELD-based survival prediction in alcoholic Hepatitis.
- Medical and surgical treatment options for polycystic liver Disease.
- Race and receipt of liver transplantation: location matters.
- Drug-induced autoimmune Hepatitis: clinical characteristics and prognosis.
- Current staging and diagnosis of gastroEsophageal varices.
- Diagnostic and therapeutic advances in hepatology: a new feature in the journal.
- Working out the bug in the accordion.
- Feasibility of in vivo MR elastographic splenic stiffness measurements in the assessment of portal hypertension.
- Impact factor: misused and overhyped?
- The international normalized ratio of prothrombin time in the model for end-stage liver Disease score: a reliable measure.
- A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic Hepatitis.
- Hyponatremia and mortality among patients on the liver-transplant waiting list.
- The need for better clinical trials.
- A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for Esophageal varices.
- Rituximab therapy for refractory Biliary strictures in immunoglobulin G4-associated cholangitis.
- Hepatic vein pressure gradient >10 mm Hg: prognostic or reflective?
- Liver transplantation for Budd-Chiari Syndrome: when is it really necessary?
- Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications.
- Significance of nodular regenerative hyperplasia occurring de novo following liver transplantation.
- Managing septic shock in patients with Cirrhosis: the role of adrenal insufficency.
- Hepatic encephalopathy as a predictor of survival in patients with end-stage liver Disease.
- Can the model for end-stage liver Disease be used to predict the prognosis in patients with Budd-Chiari syndrome?
- Risk factors for mortality after surgery in patients with Cirrhosis.
- Splanchnic artery aneurysms.
- Model for end-stage liver Disease (MELD) exception for Budd-Chiari syndrome.
- Liver transplantation in precirrhotic Biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal...
- Budd-Chiari Syndrome: Radiologic findings.
- Utility of a new model to diagnose an alcohol basis for steatoHepatitis.
- Predictive indices of morbidity and mortality after liver resection.
- Cardiac surgery in kidney and liver transplant recipients.
- Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid.
- Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney Disease (ARPKD).
- Influence of recent advances in medical management on clinical outcomes of Cirrhosis.
- Medical and ethical aspects of long-term enteral tube feeding.
- Wilson Disease--keeping the bar for diagnosis raised.
- Liver transplantation for severe intrahepatic noncirrhotic portal hypertension.
- Cardiomyopathy associated with celiac Disease.
- Ectopic varices in the gastroIntestinal tract: short- and long-term outcomes of percutaneous therapy.
- MELD accurately predicts mortality in patients with alcoholic Hepatitis.
- Esophageal variceal bleeding: primary prophylaxis.
- Performance standards for therapeutic Abdominal paracentesis.
- Sinusoidal dilatation and congestion in liver biopsy: is it always due to venous outflow impairment?
- Mutations in SEC63 cause autosomal dominant polycystic liver Disease.
- An evidence-based medicine approach to beta-blocker therapy in patients with Cirrhosis.
- Skin signs as the presenting manifestation of severe nutritional deficiency: report of 2 cases.
- Heart and liver Disease in 32 patients undergoing biopsy of both organs, with implications for heart or liver transplantation.
- MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients.
- The Budd-Chiari Syndrome.
- A pilot study of the safety and tolerability of etanercept in patients with alcoholic Hepatitis.
- Acute superior mesenteric venous thrombosis: one Disease or two?
- Hepatic veno-occlusive Disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.
- Effect of minimal listing criteria on waiting list registration for liver transplantation: a process-outcome analysis.
- Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites.
- Mutations in PRKCSH cause isolated autosomal dominant polycystic liver Disease.
- Transjugular intrahepatic portoSystemic shunts: an update.
- Is the change in MELD score a better indicator of mortality than baseline MELD score?
- Nitric oxide in liver transplantation: pathobiology and clinical implications.
- Clinical profile of autosomal dominant polycystic liver Disease.
- Transjugular intrahepatic portoSystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
- Is there life in MARS?
- Cancer antigen 125 in patients with chronic liver disease.
- Endoscopic ultrasound-guided portal-Systemic pressure gradient measurement.
- Readmission in Cirrhosis: a Growing Problem.
- Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia.
- Acute Liver Failure Prognostic Scores: Is Good Enough Good Enough?
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Education
-
Mayo School of Graduate Medical Education -
St. John's Medical College
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1831169366 | |
| NPPES Provider LastName | KAMATH | |
| NPPES Provider FirstName | PATRICK | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 397.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1831169366 |
| Last Name Of The Provider | KAMATH |
| First Name Of The Provider | PATRICK |
| View All |
Similar Doctors
|
|
Dr. Christopher H. Blevins, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harmeet Malhi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Ahlquist, MD |
|
|
Dr. Sara M. Echelmeyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edgar R. Dickson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Todd H. Baron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Philip A. Hart, MD |
|
|
Dr. Lisa A. Boardman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Suresh T. Chari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Sandborn, MD |
|
|
Mary C. Drinane, MB |
|
|
Dr. Jennifer M. Leonard, MD |
|
|
Dr. Dong Yang, MD |